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ABSTRACT
Replication-dependent histone genes are up-
regulated during the G1/S phase transition to meet
the requirement for histones to package the newly
synthesized DNA. In mammalian cells, this increment
is achieved by enhanced transcription and 3′ end
processing. The non-polyadenylated histone mRNA
3′ ends are generated by a unique mechanism in-
volving the U7 small ribonucleoprotein (U7 snRNP).
By using affinity purification methods to enrich U7
snRNA, we identified FUS/TLS as a novel U7 snRNP
interacting protein. Both U7 snRNA and histone tran-
scripts can be precipitated by FUS antibodies pre-
dominantly in the S phase of the cell cycle. More-
over, FUS depletion leads to decreased levels of cor-
rectly processed histone mRNAs and increased lev-
els of extended transcripts. Interestingly, FUS anti-
bodies also co-immunoprecipitate histone transcrip-
tional activator NPAT and transcriptional repressor
hnRNP UL1 in different phases of the cell cycle. We
further show that FUS binds to histone genes in S
phase, promotes the recruitment of RNA polymerase
II and is important for the activity of histone gene pro-
moters. Thus, FUS may serve as a linking factor that
positively regulates histone gene transcription and
3′ end processing by interacting with the U7 snRNP
and other factors involved in replication-dependent
histone gene expression.
INTRODUCTION
The expression of the metazoan replication-dependent hi-
stone genes is cell cycle-regulated to meet the requirement
for histones to package the newly synthesized DNA during
the S phase of the cell cycle. Histone mRNA levels increase
∼35-fold during theG1/S phase transition and rapidly drop
again at the end of S phase (1,2). The general transcription
factor NPAT is known to bind to replication-dependent hi-
stone gene promoters and to activate transcription during
S phase (3), resulting in a ∼5-fold increase in histone gene
transcription (2). Moreover, the S phase-dependent incre-
ment of replication-dependent histone mRNAs is also due
to more efficient histone RNA 3′ end processing. In con-
trast, the drop in histone mRNA levels at the S/G2 transi-
tion is mostly due to a rapid destabilization of the existing
mRNAs (2).
Replication-dependent histone transcripts are not pro-
cessed at the 3′ end by cleavage coupled to polyadenyla-
tion like the majority of eukaryotic pre-mRNAs. Instead,
histone mRNA 3′ end processing consists of a single cleav-
age that is carried out by the endonuclease CPSF73 and
mediated by a subset of specialized factors that recog-
nize specific elements on the nascent transcripts (4–6). His-
tone pre-mRNAs end in a conserved stem loop recognized
and bound by the hairpin- or stem loop-binding protein
(HBP/SLBP) that defines the cleavage site a few nucleotides
downstream, usually after a CA dinucleotide (4,7–8). The
other determinant of the cleavage site is the U7 small ri-
bonucleoprotein (U7 snRNP) that binds by basepairing of
the 5′ end of U7 snRNA to the histone downstream element
(HDE) located 3′ of the cleavage site (9,10).
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The U7 snRNP consists of an approximately 60-
nucleotide U7 snRNA (11–13) and an unusual ring of
Sm/Lsm proteins in which the two spliceosomal proteins
SmD1 and SmD2 are replaced by the Sm-like proteins
Lsm10 and Lsm11 (14,15). Lsm11 contains an extended N
terminus that is necessary for processing and forms a plat-
form for interactions with other factors. In particular, the
U7-specific Lsm11 protein binds to a 100 kDa zinc-finger
protein (ZFP100) which in turn interacts with SLBP and
stabilizes the complex (16–18). Lsm11 also binds to another
histone-specific processing factor, FLASH (19–21) and to
the 68 kDa subunit ofmammalian cleavage factor I (22). To-
gether, the U7 snRNP-specific protein Lsm11 and FLASH
form a binding platform to recruit a heat-labile process-
ing factor (HLF) that contains symplekin, CstF64 and
other components of cleavage/polyadenylation machinery,
including the endonuclease CPSF73 (1,21,23–25).
Two of the histone processing factors are known to be cell
cycle-regulated. These are SLBP (26) and the HLF through
its CstF64 subunit (1,25). Moreover, the U7 snRNP has
been shown to play an additional regulatory role. Together
with the hnRNP proteinUL1, it acts to repress histone gene
transcription outside of S phase (27).
By using different affinity purification strategies
for U7 snRNA, we have now identified fused in
sarcoma/translocated in liposarcoma (FUS/TLS; named
FUS thereafter) as a new factor involved in replication-
dependent histone gene expression. FUS belongs to the
FET family which includes three highly conserved, abun-
dant and ubiquitously expressed RNA-binding proteins:
FUS, EWS and TAF15 (28). FUS is predominantly
present in the nuclear matrix, although it is also found
in cytoplasmic fractions and is supposed to participate
in nucleo-cytoplasmic shuttling (29). FUS binds to both
ssDNA and dsDNA and is able to promote DNA an-
nealing and D-loop formation which implies a role in
genomic maintenance, DNA recombination and the DNA
repair pathway (30–32). FUS is also capable of binding
RNA both in the nucleus and cytoplasm, and thus a
function for FUS in RNA transport has been suggested
(29,33–36). Similar to other FET proteins, FUS associates
with the transcription factor IID complex (TFIID), as well
as directly with RNA polymerase II (RNAP2) (37) and
can regulate transcription of RNAP2 genes (30,38–40).
Interestingly, FUS was also shown to act as a repressor
of transcription for all three classes of RNA polymerase
III promoters (41). Moreover, FUS plays a role in splicing
and alternative splicing; its presence was confirmed in the
spliceosome and an association with several spliceosomal
small nuclear ribonucleoproteins and SR proteins has
been detected (34–35,42–49). Additionally, FUS may
play a role in miRNA processing as it has been found in
the large Drosha microprocessor complex (50). Several
FUS/TLS mutations have been found in familial forms of
amyotrophic lateral sclerosis (ALS) and frontotemporal
lobar degeneration (FTLD), implicating a pathogenic role
of this protein in neurodegenerative diseases (28,51–55).
In this paper, we show that FUS is associated with the
U7 snRNP/U7 snRNA and replication-dependent histone
gene transcripts (H2A, H2B, H3 and H4), predominantly
during the S phase of the cell cycle. Moreover FUS deple-
tion by RNAi induces a decrease of correctly processed his-
tonemRNAs and an increased level of extended transcripts.
The opposite effect can be observed in FUS overexpress-
ing cells. Interestingly, the histone transcriptional activator
NPAT and the transcriptional repressor hnRNP UL1 are
also co-precipitated by anti-FUS antibodies in a cell cycle-
dependent manner. Furthermore, we show, by chromatin
immunoprecipitation experiments (ChIP), that FUS binds
to replication-dependent histone gene promoters and en-
hances the binding of RNAP2 to these promoters during
S phase. FUS depletion also affects the activities of histone
gene promoters in a reporter gene assay. This strongly indi-
cates that FUS is involved in the regulation of histone gene
transcription and 3′ end processing.
MATERIALS AND METHODS
Cell culture, synchronization and cell cycle analysis
HeLa or HEK 293T cells were grown in Dulbecco’s mod-
ified Eagle medium with L-glutamine and 4.5 g/L glucose
(DMEM; Lonza) supplemented with 10% fetal calf serum
(Gibco) and antibiotics (100 U/ml penicillin, 100 g/ml
streptomycin, 0.25 g/ml amphotericin B (Sigma)) at 37◦C
in a moist atmosphere containing 5% CO2.
Synchronization of HEK 293T and HeLa cells in G2/M
was done by addition of 200 ng/ml nocodazole (Sigma-
Aldrich) to the medium for 18 h. For G2, G1 and S phase
synchronization, HEK 293T cells were arrested in G2/M
by addition of 200 ng/ml nocodazole and then collected 2,
5 and 15 h after release, respectively. For S phase synchro-
nization HeLa cells were blocked first by 2 mM thymidine
(Sigma-Aldrich) for 17 h, then released for 12 h, blocked
again by 400 M mimosine (Sigma-Aldrich) for 14 h and
collected 5 h after release. For G1 synchronization, HeLa
cells were blocked first by 2 mM thymidine for 24 h, then
released for 3 h, blocked again by 0.1 M nocodazole for
12 h and collected 5 h after release.
For cytofluorometric analysis, the cells were trypsinized,
washed with phosphate-buffered saline (PBS) and fixed by
dropwise addition of ice-cold 70% ethanol. Before staining
with propidium iodide (PI), the cells were washed twice with
PBS and resuspended in PI-staining solution (0.1% Triton
X-100 in PBS, 0.2 mg/ml RNase A (Termo Scientific), 0.02
mg/ml propidium iodide (Sigma)) and incubated for at least
30 min at room temperature in the dark. Cell cycle profiles
were analyzed by cytofluorometry with a BDFACSAria III
flow cytometer and the data was processed with FACSDiva
Version 6.1.3 software. The quality of cell synchronizations
was additionally assessed by measuring the levels of cyclin
B1 and -actin on Western blots.
For cell proliferation tests, the cells were plated in tripli-
cate in 12-well plates at 50 000 cells/well. Then cell counts
and viability were measured every 24 h for 6 days by using a
CountessTM Automated Cell Counter (Life Technologies).
The results are shown as cell proliferation curves.
Plasmid construction, lentiviral vetor production and cell
transduction
Lentiviral expression vectors encoding FLAG-tagged FUS
and enhanced blue fluorescence protein (EBFP) were con-
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structed as follows: annealed and kinased oligos encod-
ing a GSG15-FLAG tag followed by the stop codon TAA
were cloned into the BamHI andNotI sites of pCDH-CuO-
MCS-EF1-RFP (System Biosciences, Montain View, CA,
USA) to create pCDH-CuO-MCS-GSG15-FLAG-EF1-
RFP. PCR (polymerase chain reaction) amplified FUS and
EBFP cDNAs were then cloned into the XbaI and BamHI
sites of this vector. The FUS PCR product was amplified
from the full length ImaGenes Clone IRAUp969F059D.
PCR amplified Flag-mLsm11 cDNA was introduced into
pLVttR-KRAB-dsRed (56) vector by using MluI/SmaI
sites to create pLV-ttR-Flag-Lsm11-dsRed.
Expression vectors for normal and MS2-tagged U7 snR-
NAs were constructed by cloning the wild type mouse U7
snRNA sequence into pSP64 by using HpaI and StuI re-
striction sites and subsequent addition of an MS2 loop
at the 5′ end of U7 snRNA by amplification with specific
primers. Next the U7 snRNA expression cassette was am-
plified with primers adding flanking SfuI and ClaI restric-
tion sites, and ligated into a ClaI-cut pWPTS-eGFP vector
(57).
The vector for the inducible FUS knockdown was cre-
ated by digesting the pSUPuro FUS plasmid with BstXI
and SalI to isolate the fragment containing the H1 pro-
moter followed by the shRNA cassette. This fragment was
then cloned into pLV-TH by using the same restriction sites
as described in (58). pSUPuro-FUS was cloned by insert-
ing double-stranded oligos into pSUPERpuro between the
BglII and HindIII sites as described (59,60). The shRNA
expressed from pSUPuro FUS is targeting nucleotides 535–
553 of FUS mRNA, numbering according to NM 004960,
(GGACAGCAGCAAAGCTATA). All primer sequences
used for cloning are available on request.
Virus production for protein expression was essentially
performed as follows: HEK 293T cells were transfected
with pCDH-CuO-FUS-GSG15-FLAG-EF1-RFP or
pCDH-CuO-EBFP-GSG15-FLAG-EF1-RFP, pLV-ttR-
Flag-Lsm11-dsRed or pWPTS-EF1-(MS2)U7snRNA-
eGFP supplemented with pLpCMVDR8.91 and pMD2.G
according to established methods (56). Lentiviral super-
natants were collected 48, 72 and 96 h post transfection
and filtered through a 0.45 M polyethersulfone sterile
filter (Millipore). For transduction, HEK 293T or HeLa
cells were incubated with lentiviral supernatants supple-
mented with 5 g/ml polybrene (hexadimethrine bromide,
Sigma Aldrich). After 7 h, polybrene was diluted to 2.5
g/ml by the addition of fresh DMEM/10% FBS and
the procedure was repeated for two days. After expansion
of the transduced cells, highly RFP positive cells were
collected by fluorescence-activated cell sorting (FACS)
to yield a transduced cell pool. The inducible FUS and
control knockdown cell lines were generated according to
the published protocol (56) as described in (58).
To construct histone promoter reporter plasmids, the
promoter regions including the 5′UTRs were amplified
fromHeLa genomicDNAby PCR. The forward and the re-
verse primers (listed in Supplementary Table S3) contained
BglII and XhoI restriction enzyme sites, respectively, and
the PCR-amplified fragments were cloned into the BglII
and XhoI sites of pcDNA-HA-EGFP enhanced green flu-
orescence protein (EGFP) (14) to replace the human Cy-
tomegalovirus (CMV) promoter with the corresponding hi-
stone promoter amplicons. The Hist3H2A construct en-
compasses nucleotides -649 to +42, theHist2H3C construct
nucleotides from -600 to +36, the Hist2H4 construct nu-
cleotides -628 to +28, and the Hist1H3C and Hist3H3 con-
structs 645 and 660 nucleotides upstream of the start codon,
respectively.
Antibodies
The following primary antibodies were used in this work:
anti-Lsm11, anti-hnRNP UL1, anti-RPB2 (Abcam), anti-
ZN473 (Abgent), anti-symplekin, anti-V5, anti-FUS Ab1,
anti-FUS Ab2, anti-TAF15 (Bethyl Laboratories), anti-
SLBP, anti-Lsm10, anti-lamin A/C, anti-HA, anti-Cyclin
B1, anti-GADPH, antiH2A, anti-H2B, anti-H2A.Z, anti-
H4 (Santa Cruz Biotechnology), anti--actin (MP Biomed-
icals), anti-Maltose Binding Protein, anti-FLAG (Sigma
Aldrich), Y12 monoclonal antibody (recognizing SmB/B’,
SmD1) as described in (61). The following secondary anti-
bodies were used: goat anti-rabbit IgG-HRP, donkey anti-
goat IgG-HRP, goat anti-mouse IgG-HRP (Santa Cruz
Biotechnology).
A polyclonal rabbit anti-FUS antibody was prepared as
follows: a cDNA fragment, amplified by PCR, encoding the
first 286 amino acids of FUSwas cloned between the EcoRI
and XhoI sites of pET28a. The recombinant protein was
expressed in BL21(DE3) Codon Plus RIPL and purified
under denaturing conditions over Ni-NTA beads accord-
ing to the manufacturer’s instructions. The purified protein
was dialyzed against PBS, and rabbits were immunized with
the purified protein in combination withGERBUAdjuvant
LQ. Primer sequences used for cloning and are available on
request.
RNA isolation, cDNA preparation, PCR and qPCR, primer
extension
RNA was isolated from cells with TRIZOL reagent (0.8 M
guanidine thiocyanate, 0.4 M ammonium thiocyanate, 0.1
M sodium acetate pH 5.0, 5% V/V glycerol, 38% V/V sat-
urated acidic phenol, 5 mM EDTA, 0.5% sodium lauroyl-
sarcosine, in diethylpyrocarbonate-treated water (DEPC)).
The samples were vortexed vigorously and kept for 10 min
at room temperature. Then 0.5 volume of chloroform was
added, throughly mixed and after an additional incubation
of 5 min, centrifuged for 5 min at 13’600 g. The aqueous
phase was transferred to a fresh tube and re-extracted with
1 volume of chloroform. The aqueous phase was collected,
and the RNA was precipitated by addition of 1 volume of
isopropanol and overnight storage at -20◦C. The precipi-
tated RNA was centrifuged for 45 min at 16’100 g. The pel-
let was washed with 70% ethanol, centrifuged for 10 min
at 16’100 g, air-dried and resuspended in RNAse-free wa-
ter. Usually 30 g of RNA was treated with 2U TURBO
DNase (Ambion) in TURBODNase buffer in the presence
of 20U RNasin (Promega) for 1 h at 37◦C followed by stan-
dard phenol-chloroform extraction and ethanol precipita-
tion.
First strand cDNAs were synthesized in 50 l reactions
with 3 g of RNA by using 400 ng random hexamers as
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primers and 200U Superscript III Reverse Transcriptase
(SSIIIRT, Invitrogen), according to themanufacturer’s pro-
tocol. If not mentioned, 1 l of cDNA template was then
used for each PCR/qPCR amplification with gene-specific
oligonucleotide primer pairs. PCR amplifications were car-
ried out in 25 l reactions containing 2.5 l of PCR buffer
with MgCl2, nucleotide mix (0.2 mM each dNTP (Roche)),
0.5 M primers and DreamTaq DNA Polymerase (5U/l,
(Thermo scientific)). The samples were incubated for the in-
dicated number of cycles under the following conditions:
94◦C for 2min, each cycle: 94◦C for 30 s, 50◦C for 30 s, 72◦C
for 1 min and completed by incubation for 10 min at 72◦C.
For qPCR amplifications, 10l reactionmix contained 5l
of Power SYBR Green PCR Master Mix (Applied Biosys-
tems), 4 l of 0.5 mM primers mix and 1 l of 4x diluted
cDNA template. The qPCRwas performed for 40 cycles un-
der the following cycling conditions: 95◦C for 10 min, 40
cycles of 95◦C for 15 s, 60◦C for 1 min (Applied Biosystems
7900 HT thermocycler). Primers used for PCR and qPCR
are listed in the Supplementary Tables S2 and S3. The sta-
tistical significance of qPCR results was determined by Stu-
dent’s T test.
For snRNA analysis, cDNA was synthesized in a cou-
pled polyadenylation reverse transcription reaction by us-
ing 2 g of RNA for 1 h at 37◦C in RT buffer (10 mM Tris-
HCl pH 8.0, 75 mMKCl, 10mMDTT, 70mMMgCl2, 20U
RNasin, 2.5 mM of all four deoxynucleoside triphosphates,
0.5 mM of rATP, 800 ng of anchored oligo(dT) primer)
supplemented with 200U Superscript III reverse transcrip-
tase (Invitrogen) orAffinityScript reverse transcriptase (Ag-
ilent) and 5U E. coli Poly(A) polymerase (PAP, New Eng-
land Biolabs). Reactions were heat-inactivated for 10 min
at 85◦C. Then, 4 l of the 9x diluted cDNA template per
reaction were used for each qPCR amplification with a re-
verse primer complementary to the anchored sequence and
a probe-specific forward primer (600 nM each) (Suplemen-
tary Table S3).
For primer extension experiments, the U7wt-PEX primer
(Suplementary Table S3) complementary to an internal se-
quence of U7 snRNA was labeled at the 5′ end with [ -
32P]ATP (Hartmann Analytic) by polynucleotide kinase
(PNK) in PNK buffer (New England Biolabs) for 1 h at
37◦C. Next, 10 pmoles of labeled primer were hybridized
with 3 g of RNA in a thermocycler by heating to 95◦C
and slow cooling to 45◦C. The primer extension reaction
was then carried out for 2 h at 37◦C with 200U Super-
script III reverse transcriptase (Invitrogen) in RT buffer in
the presence of 10 mM DTT, 0.5 mM of all four deoxynu-
cleoside triphosphates and 20U RNasin. Primer extension
products were separated on 12% polyacrylamide/7M urea
gels in Tris-borate/EDTA buffer, pH 8.3 in the presence
of radiolabeled size marker (HpaII digested pBR 322 plas-
mid) and detected with the image analyzer (FLA-5000, Fu-
jiFilm).
Nuclear and cytoplasmic protein extract preparation
Cells were harvested by trypsinization, washed with PBS,
resuspended in Lysis Buffer (10 mM HEPES pH 7.9, 60
mM KCl, 1 mM EDTA, 1 mM MgCl2, 1 mM DTT, 0.2%
NP40, 1x EDTA-free protease inhibitor (Roche)) and in-
cubated on ice for 2 min. After centrifugation for 1 min at
800 g, the supernatant containing cytoplasmic proteins was
collected in a new tube; the pellet was washed with washing
buffer (10 mMHEPES pH 7.9, 60 mMKCl, 1 mMMgCl2,
1 mMDTT, 1x EDTA-free protease inhibitor), centrifuged
as previously and then resuspended in nuclear buffer (250
mM Tris-HCl pH 7.9, 60 mM KCl, 1 mM EDTA, 1 mM
MgCl2, 1 mM DTT, 0.2% NP40, 1x EDTA-free protease
inhibitor (Roche), 10% glycerol) and shaken vigorously for
30 min at 4◦C. After centrifugation for 30 min at 16 000 g,
the supernatant containing nuclear proteins was collected
in a new tube. The quality of the nucleo-cytoplasmic sepa-
ration was assessed byWestern blot analysis by detection of
-actin and lamin A/C.
Immunoprecipitation, RNA immunoprecipitation
For co-immunoprecipitation, the protein extracts from cells
overexpressing FLAG-tagged proteins (prepared as de-
scribed above) were gently rotated overnight at 4◦C with
anti-FLAG antibody-coupled magnetic beads (Sigma),
then washed four times with Lysis Buffer and eluted with
3xFLAG peptide or by boiling in Sample Buffer (50 mM
Tris–HCl pH 6.8, 10% glycerol, 2% SDS, 10mMDTT, 0.1%
bromophenol blue). As negative control, protein extract
from non-transduced cells was used. Alternatively, protein
extracts were incubated with Dynabeads Protein G cou-
pled to 40 g protein-specific antibodies for 1.5 h at 4◦C
and eluted by boiling in Sample Buffer. As negative con-
trol, Dynabeads Protein G coupled to either mouse IgG or
rabbit IgG were used. After elution, the immune complexes
were separated by SDS-polyacrylamide gel electrophoresis
(PAGE), transferred to polyvinylidene difluoride (PVDF)
membrane (Millipore) and detected by incubation with cor-
responding species-specific horseradish peroxidase (HRP)-
coupled secondary antibody and by using the enhanced
chemiluminescence method (ECL, GE Healthcare).
For RNA immunoprecipitation (RIP) experiments, the
nuclear and cytoplasmic protein extracts were subjected
to immunoprecipitation essentially as described above. For
the RIP shown in Figure 2, nuclear extracts from IPRA-
CELL (Mons, Belgium) were used. After washing the im-
munoprecipitated complexes with TBS-0.05% NP-40, the
co-precipitatedRNAswere eluted from the beadswithTRI-
ZOL and used for cDNA synthesis followed by qPCRas de-
scribed above. As input, the same amounts of extracts were
directly added to TRIZOL. Primers used are listed in Sup-
plementary Table S2.
Protein overexpression in bacteria
The Escherichia coli strains BL21-CodonPlus(De3)-RIPL
and BL21-CodonPlus(De3)-RIL were transformed with
pMal-derived plasmids encoding MS2-MBP fusion protein
(62) or MBP fused in frame to full length FUS protein
or to a NT FUS derivative lacking the first 165 amino
acid codons, respectively. Primer pairs used for cloning
FUS proteins in the pMal vector were designed to contain
NcoI and EcoRV restriction sites (sequences available on
request). Bacterial cultures were grown at 37◦C with con-
tinuous shaking in Luria-Bertani medium (LB) containing
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50 g/ml ampicillin and 34 g/ml chloramphenicol to an
OD600 of 0.6 to 0.8, and protein overexpression was in-
duced for 2.5 h by adding 0.3 mM IPTG (MS2-MBP) or
for 5 h by adding 0.1 mM IPTG (MBP-FUS) to the culture.
After this time, the cells were harvested by centrifugation
for 30 min at 3000 g, resuspended in Sonication Buffer (20
mM Tris-HCl pH 7.5, 200 mM NaCl; 1x EDTA-free pro-
tease inhibitor (Roche)) and sonicated with a Bioruptor R©
Plus Sonicator (Diagenode) for 15 cycles at high intensity:
30 s ON/30 s OFF at 4◦C. The cell debris were removed
by centrifugation for 15 min at 16 000 g, and supernatants
were incubated with amylose resin (New England Biolabs)
with gentle rotation for 4 h at 4◦C. After this time, the
resins were washed three times with Column Buffer (CB,
20 mM Hepes-KOH pH 7.9, 150 mM NaCl, 0.5% NP-40,
1x EDTA-free protease inhibitor (Roche)) and eluted with
10 mM maltose. After purification, the proteins were ana-
lyzed by SDS-PAGE. ForMS2-MBP purification, the amy-
lose resin was additionally washed with Wash Buffer (WB,
5 mM Na2HPO4/NaH2PO4, (pH 7.0)) and then the fusion
protein was eluted by 15 mM maltose in WB buffer and
loaded twice onto a heparin resin (GE Healthcare). The
heparin columnwaswashed twice byWBbuffer followed by
elution using Elution Buffer (EB, 20 mM Hepes-KOH pH
7.9, 100mMKCl, 15% glycerol, 0.5mMDTT, 0.2MPMSF,
1xEDTA-free protease inhibitor (Roche)). The elutedMS2-
MBP protein was quantitated and analyzed by SDS-PAGE.
Affinity purification
Purified MS2-MBP fusion protein was bound to amylose
resin by overnight incubation at 4◦C inMBPColumnBuffer
(20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA,
1x EDTA-free protease inhibitor (Roche)) with gentle ro-
tation followed by washing three times with MBP Wash
Buffer (20 mM Tris-HCl pH 7.4, 60 mM NaCl, 1 mM
EDTA, 1x EDTA-free protease inhibitor (Roche)). Cyto-
plasmic and nuclear protein extracts (prepared as described
above) from cells expressing MS2-tagged U7 snRNA or
additional copies of the normal U7 snRNA were loaded
onto the MS2-MBP-bound resin and incubated for 4 h at
4◦C with gentle rotation. Purified complexes were eluted
from the resin by 10 mM maltose in MBP Column Buffer
for 30 min at 4◦C, concentrated, and aliquots were ana-
lyzed by Western blot. Samples were either directly submit-
ted to mass spectrometric analysis or separated on a SDS
polyacrylamide gel followed by silver staining. In the lat-
ter case, selected bands were cut from the gel and submit-
ted to mass spectrometric analysis. In some cases, probes
were first loaded onto 10–50% continuous glycerol gradi-
ents (Biocomp Gradient Station) and centrifuged for 36 h
at 36 000 g. The gradients were collected into 17 fractions
(of 0.68 ml) and selected fractions were used for affinity pu-
rification.
As a second approach to enrich proteins associated with
U7 snRNA, HeLa nuclear extracts were incubated with
a biotinylated 2′-O-methyl RNA oligonucleotide comple-
mentary to U7 snRNA (AS-U7) or to 7SL RNA (AS-7SL)
for 30 min at 30◦C followed by binding to streptavidin-
coated Dynabeads for 1.5 h at 4◦C. After five subsequent
washes, the beads were boiled in sample buffer, and the pre-
cipitated material was separated by SDS-PAGE and ana-
lyzed by Western blot.
Proteomic analysis by mass spectrometry
Gel slices were destained as described (63), and proteins
were digested with sequencing grade trypsin with the ad-
dition of 0.01% ProteaseMax (Promega) as described (64).
For in-solution digestion, samples were prepared as de-
scribed (65). Peptides were separated by reversed nano-
liquid chromatography using a 20 or 60 min gradient ac-
cording to the expected sample complexity. Peptide se-
quencing was performed on a LTQ-orbitrap XL system and
data interpretation done as described (64).
Chromatin immunoprecipitation
HEK 293T cells and HEK 293T cells overexpressing
FLAG-FUS and FLAG-EBFP and FUS-depleted cells
were synchronized to G1 and S phase (as described above).
Cells were trypsinized, washed with PBS and cross-linked
with 1% formaldehyde for 10 min followed by quenching
with 125 mM glycine for 5 min. The fixed cells were washed
twice with PBS and lysed in Cell Lysis Buffer (10 mM Tris-
HCl pH 8.1, 10 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40,
1x EDTA-free protease inhibitor (Roche)) for 15 min on ice
and then centrifuged at 800 g for 5 min at 4◦C. The pel-
let was resuspended in Nuclear Lysis Buffer (50 mM Tris-
HCl pH 8.1, 5 mM EDTA, 0.5% sarkosyl, 1x EDTA-free
protease inhibitor (Roche)) and moved to DNA LoBind
Tubes (Eppendorf). The nuclear lysate was sonicated with a
Bioruptor R© Plus Sonicator (Diagenode) to generate DNA
fragments between 200 bp and 700 bp (usually 17 cycles, at
high intensity: 30 s ON/30 s OFF at 4◦C). Each time, the
sizes of DNA fragments were verified by agarose gel elec-
trophoresis. After sonication, the cell debris were removed
by centrifugation at 4000 g for 5 min at 4◦C, the concen-
tration of DNA was measured, and the supernatants were
diluted 10 times with Dilution Buffer (16.7 mM Tris-HCl
pH 8.1, 167 mM NaCl, 12 mM EDTA, 1.1% Triton X-
100, 0.01% SDS, 1x EDTA-free protease inhibitor (Roche)).
An amount of 25 g of chromatin was immunoprecipi-
tated overnight at 4◦Cwith: a) 10 l of ANTI-FLAG R©M2
Magnetic Beads; b) 5 g of anti-RPB2 antibody (Abcam,
ab10338) previously conjugated for 1 h at 4◦C with gentle
rotation with 15 l of Dynabeads R© Protein G (Life Tech-
nologies); c) 15 l of non-conjugated beads. One tenth of
the chromatin used for immunoprecipitation was kept in a
separate tube as input. After immunoprecipitation, beads
were washed three times with Low Salt Wash Buffer (20
mM Tris-HCl pH 8.1, 150 mM NaCl, 2 mM EDTA, 0.1%
SDS, 1% Triton X-100), three times with High Salt Wash
Buffer (20 mM Tris-HCl pH 8.1, 500 mM NaCl, 2 mM
EDTA, 0.1% SDS, 1% Triton X-100), three times with LiCl
Wash Buffer (10 mM Tris-HCl pH 8.1, 250 mM LiCl, 1
mMEDTA, 1%NP-40, 1% sodiumdeoxycholate) and three
times with TE Buffer (10 mM Tris-HCl pH 8.0, 1 mM
EDTA), each time for 5 min on a rotating wheel at 4◦C.
After washing, the captured chromatin was eluted by ad-
dition of Elution Buffer (1% SDS, 100 mM NaHCO3, pH
8.2) followed by vigorous shaking for 15 min at 30◦C. At
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this stage, inputs were included and treated identically as
immunoprecipitated probes. The eluted probes were trans-
ferred to new tubes and reverse-cross-linked overnight at
65◦C with NaCl at 0.3 M final concentration. Then the
probes were digested for 2 h at 50◦C by 40g/ml Proteinase
K (Thermo Scientific) and 20 g/ml RNase A (Thermo
Scientific) in PK Buffer (50 mM Tris-HCl pH 7.5, 25 mM
EDTA, 1.25%SDS). TheDNA samples were extractedwith
a Syngen PCR ME Mini Kit following the manufacturer’s
instruction. The precipitated DNAs were used for qPCR
analysis; primer pairs encompassing the promoter regions,
open reading frames and 3′ UTR regions of histone genes
are listed in Supplementary Table S4. The quantitative anal-
ysis of precipitated material was shown as a fold change
normalized to input and relative to FLAG-EBFP or shFUS
cells not treated with doxycycline. Identically treated sam-
ples from non-conjugated beads and HEK 293T cells were
used to determine non-specific background. The statistical
significance of qPCR results was determined by Student’s T
test.
Histone promoter reporter assays
HeLa cells with doxycycline-inducible FUS or control de-
pletion were induced by incubation in DMEM supple-
mented with 10 g/ml doxycycline (Sigma). For HeLa
cells without inducible depletion system, 5 × 105 cells were
seeded into a T25 flask and transfected on the next day with
1 g of pSUPuro scr (control depletion) (66) or pSUPuro
FUS plasmid. One day after transfection, transfected cells
were selected by adding 1.5 g/ml puromycin (Santa Cruz)
for 24 h.
For the promoter reporter assays, 5 × 105 cells on day
two of depletion were seeded into a T25 flask and co-
transfected on the next day with 1 g reporter plasmid
and 0.5 g pBS--globin (67) to normalize for variations
in transfection efficiency. Two days post transfection (day
4 of FUS depletion) the cells were harvested. Briefly, 1 ×
106 cells were removed to verify FUS depletion by West-
ern blotting. Total RNA was isolated from the remain-
ing cells by guanidinium thiocyanate:phenol:chlorophorm
extraction (58). After DNase treatment with the TURBO
DNA-freeTM Kit (Ambion, Life TechnologiesTM), 1 g to-
tal RNA was reverse-transcribed with 450 ng random hex-
amers, 1 x AffinityScript RT buffer, 1l AffinityScriptMul-
tiple Temperature Reverse Transcriptase, 0.4 mM dNTPs,
and 10 mM DTT (Agilent Technologies) according to the
manufacturer’s manual. To confirm successful DNase di-
gestion, controls lacking reverse transcriptase were made.
The cDNA was diluted to a RNA concentration of 8
ng/l. Quantitative real-time PCR was performed using
3 l cDNA, 1 x MESA GREEN qPCR Mastermix Plus
for SYBR R© Assay No ROX (Eurogentec) and 8 M each
of forward and reverse primer in a total volume of 15 l.
Samples were measured in duplicates in a Rotorgene6000
(Corbett) by using the following cycling conditions: 95◦C, 5
min; 95◦C, 15 s; 60◦C 1 min; 40 cycles. A melting curve was
recorded from a temperature gradient from 65◦C to 95◦C,
5 s/◦C. The analyses were performed as described in (58).
Primers used for qPCR are listed in Supplementary Table
S3 (-globin, EGFP). The statistical significance of qPCR
results was determined by Student’s T test.
RESULTS
FUS interacts with the U7 snRNP in vivo
The first indication that FUS could be involved in histone
gene expression came from a search for novel proteins inter-
acting with the U7 snRNP. For this purpose, we developed
several enrichment schemes. In a first approach, we tagged
the 5′ end of U7 snRNA with one, two or three copies of
the MS2 RNA hairpin. These constructs were stably intro-
duced into HeLa cells by lentiviral transduction. All three
U7 snRNAs were expressed, but with decreasing efficiency
as more MS2 sites were inserted (Supplementary Figure
S1). This decrease may have been due to reduced assembly
into snRNPs. Nuclear extracts from the resulting cell lines
were subjected to affinity purification by using a recombi-
nant maltose-binding protein (MBP):MS2 coat protein fu-
sion and amylose resin. As an independent approach, we
used a biotinylated oligonucleotide complementary to the
5′ end of U7 snRNA and streptavidin beads to purify en-
dogenousU7 snRNPs. Additionally or in combination with
one of the abovemethods, we collectedU7 snRNP-enriched
fractions from glycerol gradients. With these different ap-
proaches, we performed several U7 purifications that were
subjected to proteomic analysis bymass spectrometry either
directly or from gel slices after electrophoresis. Interestingly,
the FUS protein could be identified in a total of 16 different
U7-enriched fractions obtained by these various methods
(Supplementary Table S1). FUS was also identified twice in
negative controls, probably because of an unspecific interac-
tion with the affinity column (MS2-MBP bound to amylose
beads).
The presence of FUS and selected proteins involved in
replication-dependent histone gene expression was con-
firmed by Western blot in several of the the U7 snRNP-
enriched fractions. As an example, histone-specific proteins
(Lsm10, SLBP, ZFP100) as well as symplekin (a compo-
nent of the HLF) were significantly enriched in a fraction
obtained by affinity purification based on 1x MS2-tagged
U7 snRNA (Figure 1A). Importantly, probing the blot with
anti-FUS antibody confirmed the presence of FUS in the
purified fraction. However FUS was also retained, albeit
moreweakly, from an extract of non-transducedHeLa cells;
this indicated that FUS can also interact non-specifically
with either the affinity column or MS2-MBP.
Similarly, FUS could be highly enriched by affinity pu-
rification of U7 snRNPs with a biotinylated 2′-O-methyl
RNA antisense oligonucleotide (AON) complementary to
the 5′ end of U7 snRNA (AS-U7) (Figure 1B). As expected,
AS-U7 also precipitated SmB/B’, a member of the Sm ring
of the U7 snRNP. As negative control, an AON directed
against 7SL RNA precipitated only faint traces of FUS and
SmB/B’.
The FUS:U7 snRNP interaction was further confirmed
by immunoprecipitation of cytoplasmic (Cyt) and nu-
clear (Nuc) extracts from HeLa cells stably overexpressing
FLAG-Lsm11 with anti-FLAG-coupled magnetic beads
and re-elution by a 3xFLAG peptide (Figure 1C). This
experiment also indicated that FUS itself (see input) but
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Figure 1. FUS interacts with the U7 snRNP. (A) Enrichment of FUS after U7 snRNP affinity purification based on 1x MS2-tagged U7 snRNA (MS2-
U7). Western blots confirm the presence of FUS and selected proteins involved in histone RNA processing in the affinity-purified material from MS2-
U7 cells. Note that FUS from cells not transduced with the MS2-U7 vector (control cells) also binds weakly to the beads loaded with MBP-MS2. (B)
Enrichment of FUS afterU7 snRNP affinity purificationwith a biotinylated antisense oligonucleotide (ASU7) complementary toU7 snRNA.An antisense
oligonucleotide complementary to 7SLRNA (AS 7SL) was used as negative control. Western blots confirm the presence of FUS and SmB/B’ in the AS-U7
enriched fraction. Input: 10% of the usedmaterial. (C)Co-precipitation of FUSwith Lsm11.Western blots confirm the presence of FUS and FLAG-Lsm11
in the immunoprecipitated fractions from HeLa cells stably transduced with a lentiviral construct expressing FLAG-Lsm11. Cyt, cytoplasmic fraction,
Nuc, nuclear fraction, control, nuclear fraction from non-transducedHeLa cells. (D)Western blot demonstrating that FLAG-Lsm11 does not interact with
TAF15. Nuclear extracts from HeLa cells either transduced with the FLAG-Lsm11 vector or untransduced (as a negative control) were used. IP -FLAG:
immunoprecipitation with anti-FLAG antibody; input: 10% of the used material. The additional bands seen in the anti-FLAG blot of untransduced cells
are non-specific cross-reactants. In contrast, the lower band seen in the immunoprecipitate may represent a shorter form of Lsm11, possibly a degradation
product. (E) The quality of the nucleo-cytoplasmic fractionation was verified using anti-lamin A/C, anti--actin and anti-GAPDH antibodies.
also the U7 snRNP:FUS complexes are more concentrated
in the nuclear than in the cytoplasmic fraction. As, in
two of our MS analyses of U7-enriched fractions, we had
also detected TAF15 which belongs to the FET protein
family like FUS, we analyzed whether it can also be co-
precipitated with FLAG-Lsm11, but this was not the case
(Figure 1D). In this experiment we used non-transduced
HeLa cells as negative control. Moreover, we validated the
nuclear/cytoplasmic fractionation with antibodies against
lamin A/C, -actin and GAPDH (Figure 1E).
As the above experiments had indicated that FUS can
be enriched by purification or immunoprecipitation of U7
snRNPs, we wanted to know if the inverse is also true.
Thus, HeLa nuclear extracts were incubated with beads
coupled to two different anti-FUS antibodies or, as negative
control, to an antibody against the V5 tag. RNA isolated
from these precipitates was reverse transcribed by a coupled
polyadenylation reverse transcription reaction, and the con-
centrations of U7 and U6 snRNAs as well as those of the
7SL RNA were analyzed by qPCR. About 10% of the total
U7 snRNA pool was co-precipitated with FUS antibodies,
compared to only 0.4% and 0.1% for U6 and 7SL RNA, re-
spectively (Figure 2). Even though the control immunopre-
cipitation with the anti-V5 antibody brought down ∼4% of
the U7 snRNAs, both FUS-specific antibodies precipitated
∼2.4 times more U7 snRNA. Taken together, these results
indicate that FUS interacts with U7 snRNPs in vivo.
The FUS-U7 snRNP interaction, but not FUS expression, is
cell cycle-regulated
Replication-dependent histone gene expression is tightly
cell cycle-regulated. Therefore we asked whether the level
of the FUS protein or its interaction with the U7 snRNP
are subject to cell cycle regulation. To this end, HeLa cells
were arrested in G2/M by blocking for 18 h in nocoda-
zole. After release from the block, the cells were collected
every 2 h, and cell synchrony was monitored by flow cytom-
etry of propidium iodide-stained cells. Most of the cells di-
vided synchronously within 2 h of release, entered S phase
by 10–12 h after release and completed the next, partly syn-
chronous, mitosis by 18–20 h (Figure 3A). This synchro-
nizationwas confirmed by detection of cyclin B1 byWestern
blot (Supplementary Figure S2A).Nuclear and cytoplasmic
fractions were then prepared and probed by Western blot
for FUS, Lsm11, -actin (Figure 3B) and lamin A/C (Sup-
plementary Figure S2B). Interestingly, we observed a higher
level of Lsm11 in the cytoplasm, whereas FUS appeared to
be predominantly nuclear (Figure 3B). Because the analyses
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Figure 2. U7 snRNA can be enriched by FUS immunoprecipitation.
HeLa nuclear extract was subjected to immunoprecipitation with two dif-
ferent anti-FUS antibodies (dark grey) and one anti-V5 antibody (light
grey; negative control), and the levels of U7 and U6 snRNAs as well as
those of 7SL RNA were quantitated by RT-qPCR. The amounts detected
in the immunprecipitates (IP) are expressed as percent of the input. Error
bars indicate standard deviations (SD) of three technical replicates for each
antibody (i.e. six and three values for anti-FUS and anti-V5, respectively).
P-values were calculated using Student’s T-test, and statistical significance
is represented as follows: **P ≤ 0.01.
of lamin A/C (Supplementary Figure S2B) and FUS (Fig-
ure 3B) had indicated a partial leakage of nuclear content
into the cytoplasmic fractions in the earliest time points, the
unreliable, but also less relevant, 0 and 2 h points were omit-
ted from the quantitative analyses shown in Figure 3C and
D. Based on these analyses, the levels of FUS and Lsm11,
and especially the nuclear levels, showed only minor fluctu-
ations but no pronounced cell cycle regulation.
We then decided to analyze the FUS-U7 snRNP interac-
tion in synchronized cells. For this purpose, we used HEK
293T cells stably overexpressing FLAG-FUS or FLAG-
EBFP (used as negative control). The cells were synchro-
nized by nocodazole block and brought to G1, S or G2
phase after the release (Figure 4A). Protein extracts were
isolated and incubated with anti-FLAG antibody-coupled
magnetic beads. RNA isolated from the beadswas subjected
to reverse transcription by a coupled polyadenylation RT
reaction using an anchored oligo(dT) primer. U7 snRNA
and histone H3c mRNA were then quantified by qPCR.
Most U7 snRNA was precipitated with FUS in S phase
samples (Figure 4B). Interestingly, H3c mRNA was also
enriched by FLAG-FUS immunoprecipitation, and, simi-
larly to U7 snRNA, the enrichment was most pronounced
in S phase (Figure 4C). A similar S phase-specific increase
in co-precipitation could also be observed for H2Ac, H2Bc,
H2Bj, H3e and H4l mRNAs, but not for the replication-
independent H2A.Z mRNA (Figure 4D).
FUS affects the expression of U7 snRNA and replication-
dependent histone RNAs
The S phase-specific interaction of FUSwith theU7 snRNP
and replication-dependent histone gene transcripts sug-
gested that FUSmay play a role in histone RNA 3′ end pro-
cessing. To study this possibility, we measured U7 snRNA
levels and the processing of histone mRNAs in HeLa cells
depleted of or overexpressing FUS. The depletion was
achieved by expressing a shRNA targeting FUS from a
doxycycline-inducible lentiviral vector. A vector encoding
a shRNA against T-cell receptor  (TCR, which is not ex-
pressed in these cells) was used as control. Preliminary ex-
periments showed that such a depletion has minimal effects
on cell cycle progression. The FUS-depleted cells showed a
slight delay in the transition from G1 to S phase compared
to the two control cells (shFUS cells without doxycycline
induction and shTCR cells with doxycycline; Supplemen-
tary Figure S3A). Proliferation rates were close to normal
for 4 days and then started to decrease (Supplementary Fig-
ure S3B). After 7 days of doxycycline induction, the FUS
protein was reduced to ∼15% of uninduced levels (Figure
5A). Importantly, FUS depletion caused a ∼50% reduction
inU7 snRNA levels (Figure 5B). This is consistent with pre-
vious findings that FUS interacts with SMN andmay be in-
volved in snRNP biogenesis (68,69). As a second system to
study FUS effects, we used the previously described HEK
293T cells expressing FLAG-tagged FUS and the similarly
produced FLAG-EFBP cells as controls. The overexpres-
sion of FUS in the FLAG-FUS cells was ∼50% over the
normal level (Figure 5A). These cells showed a ∼35% in-
crease in U7 snRNA levels but this effect was statistically
not significant.
Based on these changes in U7 snRNA levels, we wanted
to know if histone RNA 3′ end processing is affected. For
this we measured the steady state levels of total and unpro-
cessed transcripts for various representatives of replication-
dependent histone genes by an RT-qPCR approach with
primer sets targeting either the mRNA body or a region
downstream of the processing site and used the replication-
independent H2A.Z gene as control (Figure 5D). As intro-
duced in previous papers (22,25,70), the fraction of cor-
rectly processed RNA was defined as apparent processing
efficiency. ‘Apparent’ because the levels of correctly pro-
cessed to unprocessed RNAs at steady state are not only in-
fluenced by processing but also by the turnover rates of the
precursor and its product which are likely to be different. In
the FUS-depleted cells, the apparent processing efficiency
was reduced for all five analyzed replication-dependent his-
tone genes, but not for the replication-independent H2A.Z
gene (Figure 5E). In the FLAG-FUS overexpressing cells,
the H2Ac and H2Bc genes showed an increase in the frac-
tion of correctly processed transcripts (Figure 5F). For the
H3e gene, the increase of 43% was not statistically signifi-
cant.
A more differentiated picture emerged, when we plotted
the amounts of total histone transcripts and extended ones
separately (Supplementary Figure S4A). Four genes that
had shown a reduction in the fraction of correctly processed
transcripts in the FUS-depleted cells showed reduced lev-
els of total transcripts, whereas the read-through transcripts
were slightly increased or unchanged. For the H2Ac gene,
both the total and read-through transcripts were elevated.
In the FUS overexpressing cells, the H2Ac and H2Bc genes
showed close to normal levels of total transcripts but re-
duced levels of extended ones. In contrast, for the H3e gene
both types of transcripts were more abundant. The reasons
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Figure 3. Nuclear and cytoplasmic FUS levels during the cell cycle of synchronized HeLa cells. (A)Cells synchronized by nocodazole block were analyzed
by flow cytometry of propidium iodide-stained cells. Profiles of individual time points after release of the block are shown at the top and the percentages of
cells in the indicated cell cycle phases are plotted below.Note that aDNAcontent typical forG2means that the cells are in eitherG2 orMphase. (B)Western
blots using anti--actin, anti-FUS and anti-Lsm11 antibodies to analyze the expression levels of these proteins in nuclear (left) and cytoplasmic (right)
fractions isolated at the various time points. The levels of FUS, Lsm11 and -actin were quantitated and normalized to those observed in asynchronously
dividing cells in both the nuclear (C) and cytoplasmic (D) fractions. Due to leakage of nuclear content into the cytoplasmic fractions (possibly due to
nuclear envelope breakdown during mitosis), the time points 0 and 2 h after nocodazole release were omitted from these quantitations. As, asynchronously
proliferating cells.
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Figure 4. U7 snRNAand replication-dependent histoneRNAs can be co-precipitated with FUS. (A)Cytofluorometry profiles of propidium iodide-stained,
asynchronously dividing (As) and synchronized HEK 293T cells stably overexpressing FLAG-FUS or FLAG-EBFP. The cells were synchronized by
nocodazole block followed by release for 2 (G2/M), 5 (G1) and 15 h (S). Nuclear extracts were subjected to immunoprecipitation with anti-FLAGantibody.
The amounts ofU7 snRNA (B) and histoneH3cmRNA (C) in FLAG immunoprecipitates relative to the inputweremeasured byRT-qPCRand normalized
for FLAG-EBFP. (D) Similar immunoprecipitation andRT-qPCR analyses of H2Ac, H2Bc, H2Bj, H3e, H4l mRNAs as well as the replication-independent
H2A.ZmRNA in nuclear extracts fromG1 and S phase cells. Error bars represent SD of three biological replicates.P-values were calculated using Student’s
T-test, and statistical significance is represented as follows: *P ≤ 0.05; **P ≤ 0.01.
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Figure 5. Effects of FUS depletion and overexpression onU7 snRNAand replication-dependent histone gene expression. (A)Extent of FUS depletion after
7 days of doxycycline induction of shFUS-KrabHeLa cells (left) and of FUS overproduction in FLAG-FUS expressing HEK 293T cells (right). The panels
show Western blots probed for FUS (upper panels) and -actin (lower panels, loading control) with relative amounts of FUS protein listed in between.
(B) U7 snRNA levels in FUS-depleted HeLa cells determined by RT-qPCR. The level of U7 snRNA in shFUS-Krab cells not induced with doxycycline
was used as reference (relative level = 1). (C) U7 snRNA levels in FLAG-FUS overexpressing HEK 293T cells. The level of U7 snRNA in FLAG-EBFP
expressing cells was used as reference (relative level = 1). (D) Location of primer pairs used in RT-qPCR to determine the apparent processing efficiency
of various histone genes (i.e. the ratio of correctly processed to unprocessed RNA at steady state which is influenced not only by processing but also by
turnover of the precursor and its product). For each gene, one set was located in the open reading frame to detect total (correctly processed plus extended)
histone transcripts. The second primer pair was located downstream of the processing site to detect extended transcripts. (E) Fraction of correctly cleaved
histone transcripts in FUS-depleted (FUS kd dox+) HeLa cells measured by RT-qPCR. The values have been normalized to those of cells not treated with
doxycycline. (F) Fraction of correctly cleaved histone transcripts in FLAG-FUS overexpressing HEK 293T cells (FUS OE) cells. The values have been
normalized to those of cells expressing FLAG-EBFP. Note that H2A.Z is a replication-independent histone gene that was used as a reference. Error bars
in B C, E and F represent SD of three biological replicates. P-values were calculated using Student’s T-test, and the statistical significance is represented as
follows: *P ≤ 0.05; **P ≤ 0.01.
for these different responses to FUS depletion and overex-
pression are not clear, but similar gene-specific responses to
an interference in histone RNA processing have previously
been observed by Johnsen’s laboratory (71). Nevertheless,
the net result was a reduced apparent processing efficiency
in FUS-depleted cells and an improvement in the FUS over-
expressing cells. However the data also suggested that FUS
may exert effects both on the transcription and on the pro-
cessing of replication-dependent histone transcripts.
To visualize the histone read-through transcripts, we
amplified H2Be by RT-PCR from total RNA of shFUS
cells treated or not treated with doxycycline. The levels of
GAPDH and H2A.Z transcripts used as controls were, if
anything, reduced by the FUS depletion (Supplementary
Figure S4C). In contrast, the extended transcripts of the
H2Be gene could be shown to increase uponFUS depletion.
This was in agreement with the results obtained above for
various replication-dependent histone genes by RT-qPCR
and indicated a defect in histone RNA 3′ end processing.
Taken together these results support the idea that FUS
influences the expression of several if not all replication-
dependent histone genes. It appears to act as a positive reg-
ulator of correctly processed transcripts.
FUS interacts with NPAT and hnRNP UL1 in a cell cycle-
regulated manner
We then wanted to study if FUS interacts with other fac-
tors involved in replication-dependent histone gene expres-
sion besides already established U7 components or well
characterized processing factors as shown above. In par-
ticular, we were interested to see if NPAT or hnRNP UL1
may interact with FUS. NPAT is a histone-specific tran-
scription factor involved in the transcriptional control of
replication-dependent histone gene expression during the
cell cycle (3,72). Moreover it is an important component of
histone locus bodies, subnuclear areas containing the clus-
ters of replication-dependent histone genes and various fac-
tors involved in histone gene expression (3). Depletion of
NPAT has also been shown to cause a defect in histone
RNA 3′ end processing (72,73). In contrast, hnRNP UL1
has been shown to interact with U7 snRNPs and to be in-
volved in a special regulatory activity of theU7 snRNP out-
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side of the S phase. While the U7 snRNP is an essential fac-
tor for 3′ end processing during S phase, it can, together
with hnRNPUL1, cause a transcriptional repression of the
replication-dependent histone genes in the other cell cycle
phases (27).
In an initial experiment, HeLa nuclear extract was sub-
jected to immunoprecipitation with -FUS antibodies. As
shown in Figure 6A, a significant fraction of NPAT and
hnRNP UL1 could be co-immunoprecipitated with FUS.
Moreover, as expected, based on its interaction with the
U7 snRNP, a small fraction of the general snRNP protein
SmB/B’ was also co-precipitated.
To analyze these interaction inmore detail, we bacterially
produced MBP-tagged recombinant FUS proteins. Details
of the purification are shown in Supplementary Figure S5.
The full-length (FL) protein could only be purified in small
amounts, but a deletion mutant lacking the first 165 amino
acids (NT)waswell expressed inE. coli (Figure 6B).When
similar amounts of the two proteins bound to amylose resin
were used for an affinity purification of HEK 293T nuclear
extract and the recombinant proteins with their bound in-
teraction partners were eluted with TEV protease and ana-
lyzed byWestern blotting, we found that both proteins asso-
ciated with UL1, ZFP100 and SmB/B’ (Figure 6C). How-
ever, the amount of UL1 recovered by FUSNTwas lower
than with FL FUS. Because of the poor yields of recombi-
nant FL FUS, we nevertheless decided to use FUSNT for
the subsequent experiments.
To analyze whether the interactions of FUS with NPAT
and hnRNP UL1 are cell cycle-regulated, similar binding
experiments with recombinant FUS NT were repeated
with nuclear extracts isolated from cells synchronized in the
G1, S and G2 phases of the cell cycle. As shown in Figure
6D, the binding of NPAT was most prominent with extract
from S phase-synchronized cells, while the interaction with
hnRNP UL1 was stronger in the other cell cycle phases. In
contrast, the binding of ZFP100 to FUS showed no obvi-
ous cell cycle dependence. As a control for the specificity
of this assay, we tested whether a MBP-tagged bacterially
produced version of the related FET protein TAF15 (Sup-
plementary Figure S6A) can interact with UL1. As shown
in Supplementary Figure S6B, TAF15 did not bind to UL1
from extracts of either asynchronously dividing HEK 293T
cells or cells synchronized in G1 or S phase, whereas the
binding to FUS NT could be confirmed.
Taken together, these experiments indicate that FUS in-
teracts with NPAT and hnRNP UL1. Interestingly, it does
so predominantly in those phases of the cell cycle in which
these proteins exert their effects on histone gene expression,
i.e. S phase for NPAT and non-S for hnRNP UL1.
FUS interacts with promoters of replication-dependent his-
tone genes and enhances their activity
As FUS was found to influence the level of histone mRNAs
and to be associatedwith factors such asNPATand hnRNP
UL1 involved in the expression of replication-dependent hi-
stone genes, we wanted to see whether it can associate with
histone gene regions. For this purpose, we performed a chro-
matin immunoprecipitation (ChIP) experiment with anti-
FLAG antibody in HEK 293T cells stably overexpressing
FLAG-FUS, FLAG-EBFP (negative control) or no FLAG-
tagged protein. The experiment was performed with cells
synchronized either in G1 or S phase. Different primers
were used to amplify the promoter regions, open reading
frames and 3′ UTR regions of three replication-dependent
histone genes. After subtraction of the signals of normal
HEK 293T cells, the fold enrichment of precipitated mate-
rial from FLAG-FUS cells compared to FLAG-EBFP cells
was calculated. The results shown for H2Bj in Figure 7A
and for H2Ac and H4j in Supplementary Figure S7A and
B indicated that FUS interacts predominantly with the pro-
moter regions of these three histone genes and that this in-
teraction is much stronger in the S phase than in the G1
phase. In contrast we observed no significant interaction
with the promoter region of the replication-independent
H2A.Z histone gene, be it in G1 or in S phase (Supplemen-
tary Figure S7C).
Based on these results, we performed a similar ChIP
experiment with an antibody against RNA polymerase II
(RNAP2). As shown in Figure 7B, we observed an enrich-
ment of RNAP2 at the histone H2Bj gene promoter, open
reading frame and 3′ UTR region in FUS overexpressing
cells compared to FLAG-EBFP expressing cells in S phase.
This indicated that FLAG-FUS overexpression stimulates
the presence of RNAP2 on the histone H2Bj gene. In the
same experiment, the recruitment of RNAP2 was signifi-
cantly inhibited in G1 phase. Inversely, FUS depletion in-
hibited RNAP2 loading in all three segments of the H2Bj
gene in S phase cells, but caused an enhanced recruitment in
G1 phase cells (Figure 7C). This indicates that FUS can reg-
ulate RNAP2 recruitment to histone genes during the cell
cycle.
To see whether this differential recruitment of RNAP2
to histone genes is reflected by changes in the activity of
the histone promoters, we cloned several histone promot-
ers upstream of a GFP reporter gene and tested these con-
structs after transient transfection in HeLa cells which were
subjected to a FUS depletion (see Materials andMethods).
A cotransfected -globin expression plasmid served as nor-
malizer and internal control for differences in transfection
efficiency. As shown in Figure 8, the activity of four of
the five analyzed promoters is significantly impaired by the
FUS depletion. Only the H4n promoter shows an activity
close to that of undepleted cells.
The effects of our various manipulations of FUS protein
levels on the apparent histone RNA 3′ end processing, gene
loading byRNAP2 and histone promoter activity raised the
question whether these changes might be reflected in his-
tone protein levels. Therefore we assessed the levels of var-
ious histone proteins in cells with FUS overexpression or
depletion (Supplementary Figure S8). Surprisingly, the hi-
stone protein levels were substantially unchanged. Possible
reasons for this paradoxical behavior will be discussed be-
low.
DISCUSSION
The expression of the replication-dependent histone genes
is strongly up-regulated during the G1/S phase transition
to prepare the cells for the replication of their genome. The
newly synthetized DNA has to interact with histone pro-
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Figure 6. Interactions of FUSwithNPAT and hnRNPUL1. (A)Western blot demonstrating the interaction of FUSwithNPAT, hnRNPUL1 and SmB/B’
after immunoprecipitation of HeLa nuclear extract with anti-FUS antibody. SN: supernatant; IP: immunoprecipitation. (B)Recombinant full-length FUS
(FL) and an N-terminal deletion of amino acids 1-165 (NT) were overexpressed as MBP fusions in bacteria (input) and purified using amylose beads
(purified). (C) Interaction of these recombinant FUS proteins (FL and NT) present in roughly equal amounts with hnRNP UL1, ZFP100 and SmB/B’.
(D) Cell cycle-dependence of the interactions of FUS (NT) with NPAT and hnRNP UL1. AS, asynchronously proliferating cells; S, G1, G2, cells in S,
G1, G2 phase, respectively; *: unspecific signal.
teins to form chromatin and to maintain genome stability.
Then, at the end of S phase, the availability of histones must
be reduced because an excess could be harmful to the cells.
This regulation has to ensure that the expression of the∼50
genes encoding the different histone proteins in mammals
(74) is tightly coordinated. To do so, it operates at three lev-
els: transcription, mRNA maturation and transcript stabil-
ity (2). At all these steps, specific factors are involved, some
of which are cell cycle-regulated themselves.
NPATand hnRNPUL1 are important components regu-
lating the transcription of histone genes. NPAT activates the
transcription of all the replication-dependent histone genes
by interacting with upstream promoter elements and with
other transcription factors that are specific for different hi-
stone subtypes (e.g. OCA-S or HINF-P which are specific
for H2B and H4 gene promoters, respectively) (75,76). In
contrast, hnRNPUL1 has been found to associate with the
U7 snRNP and to repress transcription under cell cycle ar-
rest conditions (27). If one assumes that this latter process
also operates in a normal cell cycle, then the transcription
of the replication-dependent histone genes would be regu-
lated both positively (in S phase, by NPAT) and negatively
(in the other phases of the cell cycle, by hnRNPUL1 in con-
junction with the U7 snRNP). Together, these mechanisms
result in a ∼5-fold regulation of histone gene transcription
over the cell cycle (2).
The efficiency of histone RNA 3′ end processing is up-
regulated ∼8-fold during the G1/S phase transition (2).
This reaction, which is unique to the replication-dependent
histone genes, is mediated by the U7 snRNP in cooperation
with several other factors (4–6). Two of these are cell cycle-
regulated, i.e. SLBP (26) and the CstF64 component of the
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Figure 7. FUS binds to promoter regions of replication-dependent histone
genes during S phase and enhances the binding of RNA polymerase II to
histone genes. (A) ChIP assays using anti-FLAG antibodies and showing
an S phase-specific enrichment of FLAG-FUS in the promoter region of
the H2Bj gene. FLAG-EBFP overexpressing cells were used as negative
control. Different qPCR reactions were performed to detect the promoter
region, open reading frame and 3′ UTR region. Similar analyses for addi-
tional genes are shown in Supplementary Figure S7. (B) ChIP experiment
performed with anti-RNAP2 antibody showing that FLAG-FUS overex-
pression stimulates the association of RNAP2 with the H2Bj gene in S
phase and inhibits its binding in G1 phase. FLAG-EBFP overexpressing
cells were used as negative control. (C) ChIP experiment performed with
anti-RNAP2 antibody showing that FUSdepletion reduces the association
ofRNAP2with theH2Bj gene in S phase and allows a stronger recruitment
in G1 phase. Cells without FUS depletion by doxycycline treatment were
used as negative control. Error bars represent the SD of three biological
replicates. P-values were calculated using Student’s T-test, and the statisti-
cal significance was represented as follows: *P ≤ 0.05; **P ≤ 0.01.
Figure 8. Effect of FUS-depletion on histone promoter reporter assays.
(A) The levels of EGFP reporter mRNA expressed under the indicated
histone promoters were analyzed in FUS-depleted HeLa cells relative to
cells not treated with doxycycline and normalized to the mRNA levels of a
co-transfected -globin gene. Error bars indicate standard deviations (SD)
of four biological replicates. P-values were calculated using Student’s T-
test, and statistical significance was represented as follows: *P≤ 0.05; **P
≤ 0.01. (B) Extent of FUS depletion assessed by Western blot. -actin is
used as loading control.
HLF (1,25). Additionally, SLBP bound to the conserved 3′-
terminal stem-loop facilitates the export of the mature hi-
stone mRNAs to the cytoplasm and enhances their trans-
lation and stability. The phosphorylation and subsequent
degradation of SLBP at the end of S phase is also respon-
sible for a rapid destabilization of all replication-dependent
histone mRNAs that results in their clearance from the cell
(26).
Our results reveal that FUS/TLS plays an important role
in the coordination and control of replication-dependent hi-
stone gene expression. Notably, FUS interacts with the U7
snRNP/U7 snRNA as well as with replication-dependent
histone gene transcripts and does so predominantly during
the S phase of the cell cycle (Figures 1, 2 and 4). Moreover,
FUS depletion and overexpression both affect the ratio
of correctly processed to read-through transcripts for sev-
eral replication-dependent histone genes (Figure 5). Taken
together, these findings indicate that FUS acts as a posi-
tive effector of histone RNA 3′ end processing. Addition-
ally, the interactions of FUS with NPAT and hnRNP UL1
(Figure 6) indicate an involvement in histone gene tran-
scription. As we found that FUS:NPAT and FUS:hnRNP
UL1 complexes are prominent in different phases of the
cell cycle, FUS may actually play a role in switching be-
tween the NPAT-mediated transcriptional activation dur-
ing S phase and the hnRNP UL1-mediated transcriptional
repression in the other phases of the cell cycle. A role for
FUS in histone gene transcription is further corroborated
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by our finding that FUS binds to histone gene promoters,
predominantly during S phase, and that its overexpression
stimulates the association of RNA polymerase II (RNAP2)
with the replication-dependent histone gene regions (Fig-
ure 7). In the same experiment a significant inhibition of
RNAP2 association with histone gene promoters was ob-
served in G1 phase cells. Moreover, FUS overexpression
had the opposite effect on the recruitment of RNAP2 to
the replication-dependent histone genes (Figure 7), and we
could demonstrate that FUS regulates the activity of his-
tone promoters (Figure 8). Thus, FUS appears to play a
role as a linking factor that enhances the transcription and
correct 3′ end processing of the replication-dependent his-
tone gene transcripts by interacting with theU7 snRNP and
other important regulatory factors. However, outside of the
S phase it may act as negative regulator in complex with hn-
RNP UL1.
Despite the fact that there have been several searches for
FUS interactors (e.g. (43,68,77)), connections with compo-
nents of the histone gene expression machinery have not yet
been reported. Possibly, if such interactions have been found
in previous studies, they may have been neglected because
they occurred at a very low level. What brought FUS to
our attention was its identification in strongly enriched U7
snRNP preparations. Moreover, we have shown that these
interactions occur in certain phases of the cell cycle which
means that they might easily be overlooked in samples from
asynchronously dividing cells.
How FUS binds to NPAT, hnRNP UL1 and the U7
snRNP and how it links these factors with each other will
have to be elucidated in more detail. In particular it is not
yet clear if all the effects on histone gene expression that
we have documented are caused by changing U7 levels or if
FUS also acts on histone gene expression (e.g. at the tran-
scriptional level) independently of the U7 snRNP. A likely
scenario is that FUS regulates the accessibility of the U7
snRNP to different partners during the cell cycle. It was pre-
viously demonstrated that hnRNP UL1 interacts with the
U7 snRNP (27), and we have shown here that FUS is asso-
ciated with hnRNP UL1 predominantly in G2 and G1 and
with the U7 snRNP and with histone transcripts predomi-
nantly during S phase. In this scenario, FUS would be im-
portant for histone RNA processing in S phase (as demon-
strated in this paper), but might also repress histone gene
transcription outside of S phase (which remains to be ana-
lyzed).
Another function of FUS in histone gene expression ap-
pears to be to stimulate histone gene transcription in S
phase and possibly to coordinate transcription with RNA
3′ end processing. Its interaction with NPAT, which is most
prominent during S phase, is most likely responsible for the
observed stimulatory effect on the presence of RNAP2 on
histone gene loci and the activation of histone gene promot-
ers. There are precedents for such a transcriptional func-
tion of FUS. In particular, it has been shown to associate
directly with RNAP2 and with the general transcription
factor TFIID (37) and to participate in the recognition of
promoters by binding to certain transcriptional activators
(38,39).
Additionally, the interaction between FUS and NPAT
could play a role in coupling histone gene transcrip-
tion and 3′ end processing. In contrast to polyadeny-
lated mRNAs where a coupling between transcription and
cleavage/polyadenylation is well established (78), the evi-
dence for a similar mechanism acting on the replication-
dependent histone genes is scarce. In an in vitro transcrip-
tion system from Drosophila, Adamson and Price did not
observe a pronounced coupling (79). Evidence from the
Manley lab that the phosphorylation of threonine 4 (Thr4)
in the C-terminal domain (CTD) of RNAP2 is required
for histone RNA 3′ end processing (80) strongly stimulated
the concept of coupling for histone genes, but the Thr4
phosphorylated form of RNAP2 was then also found to
be associated with other genes and was suggested to play
a more general role in transcriptional elongation (81,82).
However, the findings that NPAT can interact with Lsm11
via FLASH and that FLASH interacts with histone gene
promoters (19) and that NPAT depletion affects the effi-
ciency of histone RNA 3′ end processing (73) suggested that
the transcription and processing of replication-dependent
histone RNAs are somehow linked throughNPAT, FLASH
and the U7 snRNP. In such a scheme, FUS could play an
important role, as we have shown it to interact with NPAT
and the U7 snRNP and to promote RNAP2 occupancy
on histone genes during S phase. More specifically, FUS,
in concert with NPAT and other histone-specific and gen-
eral transcription factors, might enhance both the presence
and activity of RNAP2 on histone genes and the loading of
the CTD domain with the U7 snRNP or with other histone
RNA processing factors.
Despite the fact that histone gene transcription and 3′
end processingwere affected by our experimentalmanipula-
tions of the FUS level, the levels of histone proteins seemed
to be unaffected (Supplementary Figure S8). A likely expla-
nation for this paradoxical result is that too high or too low
histone protein levels should be toxic to the cells. Thus, a cell
should either adapt its proliferation to the available histone
levels or die. Our depletion and overexpression conditions
are not so extreme that an adaptation is not possible. In fact,
the cell cycle and proliferation assays shown in Supplemen-
tary Figure S3 indicate that this is occurring in our system
in the sense that proliferation rates appear to be adapted to
the amount of FUS present.
As expected for a factor that has many other functions,
the levels of the FUS protein are not regulated during the
cell cycle (Figure 3). However, as mentioned, several of its
interactions with components of the histone gene expres-
sion machinery are specific for certain phases of the cell
cycle. This raises the question how these interactions may
be regulated. Obvious and mutually not exclusive possibil-
ities are that certain components of these complexes may
either be cell cycle-regulated themselves or subject to post-
translational modifications which alter the assembly, sta-
bility or the turnover of the complexes. For example, the
level of NPAT protein has been shown to peak at the G1/S
boundary, remain high in mid-S phase and then to de-
crease (83,84). Moreover, NPAT promotes S phase entry,
and this effect is enhanced by the cyclin E–CDK2 kinase
that selectively phosphorylates NPAT at the G1/S border at
nuclear foci related to Cajal bodies. This phosphorylation
also stimulates NPAT-mediated transcriptional activation
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of replication-dependent histone genes (3,72,84–86). As al-
ready mentioned, the phosphorylation of the RNAP2 CTD
onThr4may also play a role in histone RNA3′ end process-
ing (80). Last but not least, FUS has also been shown to in-
fluence the phosphorylation status of the RNAP2. It binds
to the CTD and inhibits premature Ser2 hyperphosphory-
lation of this domain (86). However, to fully elucidate how
the various interactions of FUS with the histone gene ex-
pression machinery are regulated will be a challenging task
for future investigations.
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Supplementary Data are available at NAR Online.
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